CUSIP: 25456J104
Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,066,076
-
Share change
-
+2,066,076
-
Total reported value
-
$20,695,000
-
Price per share
-
$10.08
-
Number of holders
-
13
-
Value change
-
+$20,695,000
-
Number of buys
-
13
Quarterly Holders Quick Answers
What is CUSIP 25456J104?
CUSIP 25456J104 identifies DPRX - DIPEXIUM PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 25456J104:
Institutional Holders of DIPEXIUM PHARMACEUTICALS INC - COM (DPRX) as of Q1 2014
As of 31 Mar 2014,
DIPEXIUM PHARMACEUTICALS INC - COM (DPRX) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,066,076 shares.
The largest 10 holders included
KINGDON CAPITAL MANAGEMENT, L.L.C., Broadfin Capital, LLC, GREAT POINT PARTNERS LLC, Pine River Capital Management L.P., Timpani Capital Management LLC, SPHERA FUNDS MANAGEMENT LTD., HIGHLAND CAPITAL MANAGEMENT LP, MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, and PEAK6 Investments, L.P..
This page lists
13
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.